Bacterial	B-taxonomy_domain
Microcompartments	B-complex_assembly
(	O
BMCs	B-complex_assembly
)	O
are	O
proteinaceous	O
organelles	O
that	O
encapsulate	O
critical	O
segments	O
of	O
autotrophic	O
and	O
heterotrophic	O
metabolic	O
pathways	O
;	O
they	O
are	O
functionally	O
diverse	O
and	O
are	O
found	O
across	O
23	O
different	O
phyla	O
.	O

The	O
PduL	B-protein_type
structure	B-evidence
,	O
in	O
the	O
context	O
of	O
the	O
catalytic	O
core	O
,	O
completes	O
our	O
understanding	O
of	O
the	O
structural	O
basis	O
of	O
cofactor	O
recycling	O
in	O
the	O
metabolosome	B-complex_assembly
lumen	O
.	O

This	O
study	O
describes	O
the	O
structure	B-evidence
of	O
a	O
novel	O
phosphotransacylase	B-protein_type
enzyme	O
that	O
facilitates	O
the	O
recycling	O
of	O
the	O
essential	O
cofactor	O
acetyl	B-chemical
-	I-chemical
CoA	I-chemical
within	O
a	O
bacterial	B-taxonomy_domain
organelle	O
and	O
discusses	O
the	O
properties	O
of	O
the	O
enzyme	O
'	O
s	O
active	B-site
site	I-site
and	O
how	O
it	O
is	O
packaged	O
into	O
the	O
organelle	O
.	O

This	O
involves	O
a	O
BMC	B-complex_assembly
-	O
encapsulated	O
signature	O
enzyme	O
that	O
generates	O
a	O
toxic	O
and	O
/	O
or	O
volatile	O
aldehyde	B-chemical
that	O
the	O
BMC	B-complex_assembly
shell	B-structure_element
sequesters	O
from	O
the	O
cytosol	O
.	O

General	O
biochemical	O
model	O
of	O
aldehyde	B-protein_state
-	I-protein_state
degrading	I-protein_state
BMCs	B-complex_assembly
(	O
metabolosomes	B-complex_assembly
)	O
illustrating	O
the	O
common	O
metabolosome	B-complex_assembly
core	O
enzymes	O
and	O
reactions	O
.	O

*	O
PduL	B-protein_type
from	O
these	O
functional	O
types	O
of	O
metabolosomes	B-complex_assembly
were	O
purified	O
in	O
this	O
study	O
.	O

More	O
recently	O
,	O
a	O
second	O
type	O
of	O
PTAC	B-protein_type
without	O
any	O
sequence	O
homology	O
to	O
Pta	B-protein_type
was	O
identified	O
.	O

Another	O
distinctive	O
feature	O
of	O
BMC	B-protein_state
-	I-protein_state
associated	I-protein_state
PduL	B-protein_type
homologs	O
is	O
an	O
N	O
-	O
terminal	O
encapsulation	B-structure_element
peptide	I-structure_element
(	O
EP	B-structure_element
)	O
that	O
is	O
thought	O
to	O
“	O
target	O
”	O
proteins	O
for	O
encapsulation	O
by	O
the	O
BMC	B-complex_assembly
shell	B-structure_element
.	O

This	O
is	O
a	O
major	O
gap	O
in	O
our	O
understanding	O
of	O
metabolosome	B-complex_assembly
-	O
encapsulated	O
biochemistry	O
and	O
cofactor	O
recycling	O
.	O

Structure	B-experimental_method
Determination	I-experimental_method
of	O
PduL	B-protein_type

While	O
purifying	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
sPduL	B-protein
,	O
we	O
observed	O
a	O
tendency	O
to	O
aggregation	O
as	O
described	O
previously	O
,	O
with	O
a	O
large	O
fraction	O
of	O
the	O
expressed	O
protein	O
found	O
in	O
the	O
insoluble	O
fraction	O
in	O
a	O
white	O
,	O
cake	O
-	O
like	O
pellet	O
.	O

Similar	O
differences	O
in	O
solubility	O
were	O
observed	O
for	O
pPduL	B-protein
and	O
rPduL	B-protein
when	O
comparing	O
EP	B-protein_state
-	I-protein_state
truncated	I-protein_state
forms	O
to	O
the	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
protein	O
,	O
but	O
none	O
were	O
quite	O
as	O
dramatic	O
as	O
for	O
sPduL	B-protein
.	O
We	O
confirmed	O
that	O
all	O
homologs	O
were	O
active	B-protein_state
(	O
S1a	O
and	O
S1b	O
Fig	O
).	O

(	O
b	O
)	O
Cartoon	O
representation	O
of	O
the	O
structure	B-evidence
colored	O
by	O
domains	O
and	O
including	O
secondary	O
structure	B-evidence
numbering	O
.	O

Residues	O
in	O
this	O
region	O
(	O
Gln42	B-residue_name_number
,	O
Pro43	B-residue_name_number
,	O
Gly44	B-residue_name_number
),	O
covering	O
the	O
active	B-site
site	I-site
,	O
are	O
strongly	B-protein_state
conserved	I-protein_state
(	O
Fig	O
3	O
).	O

This	O
structural	O
arrangement	O
is	O
completely	O
different	O
from	O
the	O
functionally	O
related	O
Pta	B-protein_type
,	O
which	O
is	O
composed	O
of	O
two	O
domains	B-structure_element
,	O
each	O
consisting	O
of	O
a	O
central	O
flat	O
beta	B-structure_element
sheet	I-structure_element
with	O
alpha	B-structure_element
-	I-structure_element
helices	I-structure_element
on	O
the	O
top	O
and	O
bottom	O
.	O

Sequence	O
logo	O
calculated	O
from	O
the	O
multiple	B-experimental_method
sequence	I-experimental_method
alignment	I-experimental_method
of	O
PduL	B-protein_type
homologs	O
(	O
see	O
Materials	O
and	O
Methods	O
),	O
but	O
not	B-protein_state
including	I-protein_state
putative	O
EP	B-structure_element
sequences	O
.	O

The	O
interface	B-site
between	O
the	O
two	O
chains	O
buries	O
882	O
Å2	O
per	O
monomer	B-oligomeric_state
and	O
is	O
mainly	O
formed	O
by	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
2	I-structure_element
and	I-structure_element
4	I-structure_element
and	O
parts	O
of	O
β	B-structure_element
-	I-structure_element
sheets	I-structure_element
12	I-structure_element
and	I-structure_element
14	I-structure_element
,	O
as	O
well	O
as	O
a	O
π	O
–	O
π	O
stacking	O
of	O
the	O
adenine	B-chemical
moiety	O
of	O
CoA	B-chemical
with	O
Phe116	B-residue_name_number
of	O
the	O
adjacent	O
chain	O
(	O
Fig	O
4c	O
).	O

(	O
d	O
)	O
Surface	O
representation	O
of	O
the	O
structure	B-evidence
with	O
indicated	O
conservation	O
(	O
red	O
:	O
high	O
,	O
white	O
:	O
intermediate	O
,	O
yellow	O
:	O
low	O
).	O

Active	B-site
Site	I-site
Properties	O

The	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
aligns	B-experimental_method
well	O
with	O
the	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
(	O
0	O
.	O
43	O
Å	O
rmsd	B-evidence
over	O
2	O
,	O
361	O
atoms	O
for	O
the	O
monomer	B-oligomeric_state
,	O
0	O
.	O
83	O
Å	O
over	O
5	O
,	O
259	O
aligned	O
atoms	O
for	O
the	O
dimer	B-oligomeric_state
).	O

rPduL	B-protein
full	B-protein_state
length	I-protein_state
runs	O
as	O
Mw	B-evidence
=	O
140	O
.	O
3	O
kDa	O
+/−	O
1	O
.	O
2	O
%	O
and	O
Mn	B-evidence
=	O
140	O
.	O
5	O
kDa	O
+/−	O
1	O
.	O
2	O
%.	O

This	O
corresponds	O
to	O
an	O
oligomeric	O
state	O
of	O
six	B-oligomeric_state
subunits	I-oligomeric_state
(	O
calculated	O
molecular	B-evidence
weight	I-evidence
of	O
144	O
kDa	O
).	O

Collectively	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
N	O
-	O
terminal	O
EP	B-structure_element
of	O
PduL	B-protein_type
plays	O
a	O
role	O
in	O
defining	O
the	O
quaternary	O
structure	O
of	O
the	O
protein	O
.	O

The	O
closest	O
structural	O
homolog	O
of	O
the	O
PduL	B-protein_type
barrel	B-structure_element
domain	I-structure_element
is	O
a	O
subdomain	O
of	O
a	O
multienzyme	O
complex	O
,	O
the	O
alpha	B-structure_element
subunit	I-structure_element
of	O
ethylbenzene	B-protein_type
dehydrogenase	I-protein_type
(	O
S5b	O
Fig	O
,	O
rmsd	B-evidence
of	O
2	O
.	O
26	O
Å	O
over	O
226	O
aligned	O
atoms	O
consisting	O
of	O
one	O
beta	B-structure_element
barrel	I-structure_element
and	O
one	O
capping	B-structure_element
helix	I-structure_element
).	O

The	O
PduL	B-protein_type
signature	O
primary	O
structure	O
,	O
two	O
PF06130	B-structure_element
domains	O
,	O
occurs	O
in	O
some	O
multidomain	O
proteins	O
,	O
most	O
of	O
them	O
annotated	O
as	O
Acks	B-protein_type
,	O
suggesting	O
that	O
PduL	B-protein_type
may	O
also	O
replace	O
Pta	B-protein_type
in	O
variants	O
of	O
the	O
phosphotransacetylase	B-protein_type
-	O
Ack	B-protein_type
pathway	O
.	O

Our	O
PduL	B-protein_type
crystals	B-evidence
contained	O
CoA	B-chemical
that	O
was	O
captured	O
from	O
the	O
Escherichia	B-species
coli	I-species
cytosol	O
,	O
indicating	O
that	O
the	O
“	O
ground	O
state	O
”	O
of	O
PduL	B-protein_type
is	O
in	O
the	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
form	O
;	O
this	O
could	O
provide	O
an	O
elegantly	O
simple	O
means	O
of	O
guaranteeing	O
a	O
1	O
:	O
1	O
ratio	O
of	O
CoA	B-complex_assembly
:	I-complex_assembly
PduL	I-complex_assembly
within	O
the	O
metabolosome	B-complex_assembly
lumen	O
.	O

Active	B-site
Site	I-site
Identification	O
and	O
Structural	O
Insights	O
into	O
Catalysis	O

As	O
expected	O
,	O
the	O
amino	O
acid	O
sequence	O
conservation	O
is	O
highest	O
in	O
the	O
region	O
around	O
the	O
proposed	O
active	B-site
site	I-site
(	O
Fig	O
4d	O
);	O
highly	B-protein_state
conserved	I-protein_state
residues	O
are	O
also	O
involved	O
in	O
CoA	B-chemical
binding	O
(	O
Figs	O
2a	O
and	O
3	O
,	O
residues	O
Ser45	B-residue_name_number
,	O
Lys70	B-residue_name_number
,	O
Arg97	B-residue_name_number
,	O
Leu99	B-residue_name_number
,	O
His204	B-residue_name_number
,	O
Asn211	B-residue_name_number
).	O

The	O
native	O
substrate	O
for	O
the	O
forward	O
reaction	O
of	O
rPduL	B-protein
and	O
pPduL	B-protein
,	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
,	O
most	O
likely	O
binds	O
to	O
the	O
enzyme	O
in	O
the	O
same	O
way	O
at	O
the	O
observed	O
nucleotide	B-chemical
and	O
pantothenic	B-chemical
acid	I-chemical
moiety	O
,	O
but	O
the	O
propionyl	O
group	O
in	O
the	O
CoA	B-chemical
-	I-chemical
thioester	I-chemical
might	O
point	O
in	O
a	O
different	O
direction	O
.	O

There	O
could	O
be	O
some	O
intrinsic	O
biochemical	O
difference	O
between	O
the	O
two	O
enzymes	O
that	O
renders	O
PduL	B-protein_type
a	O
more	O
attractive	O
candidate	O
for	O
encapsulation	O
in	O
a	O
BMC	B-complex_assembly
—	O
for	O
example	O
,	O
PduL	B-protein_type
might	O
be	O
more	O
amenable	O
to	O
tight	O
packaging	O
,	O
or	O
is	O
better	O
suited	O
for	O
the	O
chemical	O
microenvironment	O
formed	O
within	O
the	O
lumen	O
of	O
the	O
BMC	B-complex_assembly
,	O
which	O
can	O
be	O
quite	O
different	O
from	O
the	O
cytosol	O
.	O

Although	O
a	O
Thr1Ser	B-mutant
mutant	B-protein_state
is	O
active	B-protein_state
,	O
it	O
is	O
less	O
efficient	O
compared	O
with	O
wild	B-protein_state
type	I-protein_state
because	O
of	O
the	O
unfavourable	O
orientation	O
of	O
Ser1	B-residue_name_number
towards	O
incoming	O
substrates	O
.	O

Release	O
of	O
the	O
propeptides	B-structure_element
creates	O
a	O
functionally	O
active	B-protein_state
CP	B-complex_assembly
that	O
cleaves	O
proteins	O
into	O
short	O
peptides	O
.	O

Although	O
the	O
chemical	O
nature	O
of	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
and	O
hence	O
substrate	O
preferences	O
are	O
unique	O
to	O
each	O
of	O
the	O
distinct	O
active	B-protein_state
β	B-protein
subunits	I-protein
,	O
all	O
active	B-site
sites	I-site
employ	O
an	O
identical	O
reaction	O
mechanism	O
to	O
hydrolyse	O
peptide	O
bonds	O
.	O

An	O
alternative	O
candidate	O
for	O
deprotonating	O
the	O
Thr1	B-residue_name_number
hydroxyl	O
group	O
is	O
the	O
side	O
chain	O
of	O
Lys33	B-residue_name_number
as	O
it	O
is	O
within	O
hydrogen	O
-	O
bonding	O
distance	O
to	O
Thr1OH	B-residue_name_number
(	O
2	O
.	O
7	O
Å	O
).	O

These	O
results	O
indicate	O
that	O
the	O
β1	B-protein
and	O
β2	B-protein
proteolytic	O
activities	O
are	O
not	O
essential	O
for	O
cell	O
survival	O
.	O

The	O
extremely	O
weak	O
growth	O
of	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
pp	B-chemical
cis	B-protein_state
described	O
by	O
Chen	O
and	O
Hochstrasser	O
compared	O
with	O
the	O
inviability	O
reported	O
by	O
Heinemeyer	O
et	O
al	O
.	O
prompted	O
us	O
to	O
analyse	O
this	O
discrepancy	O
.	O

Sequencing	B-experimental_method
of	I-experimental_method
the	I-experimental_method
plasmids	I-experimental_method
,	O
testing	O
them	O
in	O
both	O
published	O
yeast	B-taxonomy_domain
strain	O
backgrounds	O
and	O
site	B-experimental_method
-	I-experimental_method
directed	I-experimental_method
mutagenesis	I-experimental_method
revealed	O
that	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
pp	B-chemical
cis	B-protein_state
is	O
viable	O
,	O
but	O
suffers	O
from	O
a	O
marked	O
growth	O
defect	O
that	O
requires	O
extended	O
incubation	O
of	O
4	O
–	O
5	O
days	O
for	O
initial	O
colony	O
formation	O
(	O
Table	O
1	O
and	O
Supplementary	O
Methods	O
).	O

Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
positions	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
via	O
hydrogen	O
bonding	O
(∼	O
2	O
.	O
8	O
Å	O
)	O
in	O
a	O
perfect	O
trajectory	O
for	O
the	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
(	O
Fig	O
.	O
1b	O
and	O
Supplementary	O
Fig	O
.	O
2b	O
).	O

Next	O
,	O
we	O
examined	O
the	O
position	O
of	O
the	O
β5	B-protein
propeptide	B-structure_element
in	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
.	O

Next	O
,	O
we	O
determined	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
a	O
chimeric	B-protein_state
yCP	B-complex_assembly
having	O
the	O
yeast	B-taxonomy_domain
β1	B-protein
-	O
propeptide	B-structure_element
replaced	B-experimental_method
by	I-experimental_method
its	O
β5	B-protein
counterpart	B-structure_element
.	O

As	O
proven	O
by	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
crystal	B-evidence
structures	I-evidence
,	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
hydrogen	O
bonds	O
to	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
.	O
Although	O
this	O
interaction	O
was	O
not	O
observed	O
for	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
(	O
Fig	O
.	O
2c	O
and	O
Supplementary	O
Fig	O
.	O
4c	O
,	O
i	O
),	O
exchange	B-experimental_method
of	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
by	O
Val	B-residue_name
in	O
β2	B-protein
,	O
a	O
conservative	O
mutation	O
regarding	O
size	O
but	O
drastic	O
with	O
respect	O
to	O
polarity	O
,	O
was	O
found	O
to	O
inhibit	O
maturation	O
of	O
this	O
subunit	O
(	O
Fig	O
.	O
2d	O
and	O
Supplementary	O
Fig	O
.	O
4e	O
,	O
j	O
).	O

A	O
proposed	O
catalytic	B-site
tetrad	I-site
model	O
involving	O
Thr1OH	B-residue_name_number
,	O
Thr1NH2	B-residue_name_number
,	O
Lys33NH2	B-residue_name_number
and	O
Asp17Oδ	B-residue_name_number
,	O
as	O
well	O
as	O
a	O
nucleophilic	O
water	B-chemical
molecule	O
as	O
the	O
proton	O
shuttle	O
appeared	O
to	O
accommodate	O
all	O
possible	O
views	O
of	O
the	O
proteasomal	O
active	B-site
site	I-site
.	O

Twenty	O
years	O
later	O
,	O
with	O
a	O
plethora	O
of	O
yCP	B-complex_assembly
X	B-evidence
-	I-evidence
ray	I-evidence
structures	I-evidence
in	O
hand	O
,	O
we	O
decided	O
to	O
re	O
-	O
analyse	O
the	O
active	B-site
site	I-site
of	O
the	O
proteasome	B-complex_assembly
and	O
to	O
resolve	O
the	O
uncertainty	O
regarding	O
the	O
nature	O
of	O
the	O
general	O
base	O
.	O

Structural	B-experimental_method
comparison	I-experimental_method
of	O
the	O
β5	B-mutant
-	I-mutant
L	I-mutant
(-	I-mutant
49	I-mutant
)	I-mutant
S	I-mutant
-	I-mutant
K33A	I-mutant
and	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
active	B-site
sites	I-site
revealed	O
that	O
mutation	B-experimental_method
of	O
Lys33	B-residue_name_number
to	O
Ala	B-residue_name
creates	O
a	O
cavity	O
that	O
is	O
filled	O
with	O
Thr1	B-residue_name_number
and	O
the	O
remnant	O
propeptide	B-structure_element
.	O

X	B-evidence
-	I-evidence
ray	I-evidence
data	I-evidence
on	O
the	O
β5	B-mutant
-	I-mutant
D166N	I-mutant
mutant	B-protein_state
indicate	O
that	O
the	O
β5	B-protein
propeptide	B-structure_element
is	O
hydrolysed	O
,	O
but	O
due	O
to	O
reorientation	O
of	O
Ser129OH	B-residue_name_number
,	O
the	O
interaction	O
with	O
Asn166Oδ	B-residue_name_number
is	O
disrupted	O
(	O
Supplementary	O
Fig	O
.	O
8a	O
).	O

These	O
results	O
suggest	O
that	O
Asp166	B-residue_name_number
and	O
Ser129	B-residue_name_number
function	O
as	O
a	O
proton	O
shuttle	O
and	O
affect	O
the	O
protonation	O
state	O
of	O
Thr1N	B-residue_name_number
during	O
autolysis	B-ptm
and	O
catalysis	O
.	O

Substitution	B-experimental_method
of	O
the	O
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
by	O
Cys	B-residue_name

Despite	O
propeptide	B-ptm
hydrolysis	I-ptm
,	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
active	B-site
site	I-site
is	O
catalytically	B-protein_state
inactive	I-protein_state
(	O
Fig	O
.	O
4b	O
and	O
Supplementary	O
Fig	O
.	O
9a	O
).	O

The	O
benefit	O
of	O
Thr	B-residue_name
over	O
Ser	B-residue_name
as	O
the	O
active	O
-	O
site	O
nucleophile	O

Nevertheless	O
,	O
inhibitor	B-complex_assembly
complex	I-complex_assembly
structures	B-evidence
indicate	O
identical	O
binding	O
modes	O
compared	O
with	O
the	O
WT	B-protein_state
yCP	B-complex_assembly
structures	B-evidence
,	O
with	B-protein_state
the	I-protein_state
same	I-protein_state
inhibitors	I-protein_state
.	O

Consistent	O
with	O
this	O
model	O
,	O
the	O
positively	O
charged	O
Thr1	B-residue_name_number
N	O
terminus	O
is	O
engaged	O
in	O
hydrogen	O
bonds	O
with	O
inhibitory	O
compounds	O
like	O
fellutamide	B-chemical
B	I-chemical
(	O
ref	O
.),	O
α	B-chemical
-	I-chemical
ketoamides	I-chemical
,	O
homobelactosin	B-chemical
C	I-chemical
(	O
ref	O
.)	O
and	O
salinosporamide	B-chemical
A	I-chemical
(	O
ref	O
.).	O

The	O
resulting	O
uncharged	O
Thr1NH2	B-residue_name_number
is	O
hydrogen	O
-	O
bridged	O
to	O
the	O
C3	O
-	O
OH	O
group	O
.	O

Breakdown	O
of	O
this	O
tetrahedral	O
transition	O
state	O
releases	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
that	O
is	O
protonated	O
by	O
aspartic	B-residue_name_number
acid	I-residue_name_number
166	I-residue_name_number
via	O
Ser129OH	B-residue_name_number
to	O
yield	O
Thr1NH3	B-residue_name_number
+.	O

In	O
accord	O
with	O
the	O
proposed	O
Thr1	B-residue_name_number
–	O
Lys33	B-residue_name_number
–	O
Asp17	B-residue_name_number
catalytic	B-site
triad	I-site
,	O
crystallographic	B-evidence
data	I-evidence
on	O
the	O
proteolytically	B-protein_state
inactive	I-protein_state
β5	B-mutant
-	I-mutant
T1C	I-mutant
mutant	B-protein_state
demonstrate	O
that	O
the	O
interaction	O
of	O
Lys33NH2	B-residue_name_number
and	O
Cys1	B-residue_name_number
is	O
broken	O
.	O

To	O
investigate	O
why	O
the	O
CP	B-complex_assembly
specifically	O
employs	O
threonine	B-residue_name
as	O
its	O
active	B-site
-	I-site
site	I-site
residue	I-site
,	O
we	O
used	O
a	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
of	O
the	O
yCP	B-complex_assembly
and	O
characterized	O
it	O
biochemically	B-experimental_method
and	I-experimental_method
structurally	I-experimental_method
.	O

Activity	B-experimental_method
assays	I-experimental_method
with	O
the	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
revealed	O
reduced	O
turnover	O
of	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
.	O

Notably	O
,	O
proteolytically	B-protein_state
active	I-protein_state
proteasome	B-complex_assembly
subunits	O
from	O
archaea	B-taxonomy_domain
,	O
yeast	B-taxonomy_domain
and	O
mammals	B-taxonomy_domain
,	O
including	O
constitutive	O
,	O
immuno	O
-	O
and	O
thymoproteasome	O
subunits	O
,	O
either	O
encode	O
Thr	B-residue_name
or	O
Ile	B-residue_name
at	O
position	O
3	B-residue_number
,	O
indicating	O
the	O
importance	O
of	O
the	O
Cγ	O
for	O
fixing	O
the	O
position	O
of	O
the	O
nucleophilic	O
Thr1	B-residue_name_number
.	O

Similarly	O
,	O
although	O
the	O
serine	B-residue_name
mutant	B-protein_state
is	O
active	B-protein_state
,	O
threonine	B-residue_name
is	O
more	O
efficient	O
in	O
the	O
context	O
of	O
the	O
proteasome	B-complex_assembly
active	B-site
site	I-site
.	O

(	O
a	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
matured	B-protein_state
WT	B-protein_state
β1	B-protein
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
.	O

While	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
of	O
the	O
β1	B-protein
and	O
β2	B-protein
prosegments	B-structure_element
fit	O
the	O
S1	B-site
pocket	I-site
,	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
of	O
the	O
β5	B-protein
propeptide	B-structure_element
occupies	O
the	O
S2	B-site
pocket	I-site
.	O

The	O
hydrogen	O
bond	O
between	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
OH	O
and	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
(∼	O
2	O
.	O
8	O
Å	O
)	O
is	O
indicated	O
by	O
a	O
black	O
dashed	O
line	O
.	O

The	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
residues	O
of	O
both	O
prosegments	B-structure_element
point	O
into	O
the	O
S1	B-site
pocket	I-site
.	O

While	O
the	O
residues	O
(-	B-residue_range
2	I-residue_range
)	I-residue_range
to	I-residue_range
(-	I-residue_range
4	I-residue_range
)	I-residue_range
vary	O
in	O
their	O
conformation	O
,	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Ala1	B-residue_name_number
are	O
located	O
in	O
all	O
structures	B-evidence
at	O
the	O
same	O
positions	O
.	O

(	O
d	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
matured	B-protein_state
β2	B-protein
active	B-site
site	I-site
,	O
the	O
WT	B-protein_state
β2	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
β2	B-mutant
-	I-mutant
T	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
V	I-mutant
mutant	B-protein_state
propeptide	B-structure_element
.	O

(	O
a	O
)	O
Hydrogen	B-site
-	I-site
bonding	I-site
network	I-site
at	O
the	O
mature	B-protein_state
WT	B-protein_state
β5	B-protein
proteasomal	O
active	B-site
site	I-site
(	O
dotted	O
lines	O
).	O

The	O
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
is	O
depicted	O
in	O
blue	O
,	O
the	O
propeptide	B-structure_element
segment	O
and	O
the	O
peptide	O
substrate	O
are	O
coloured	O
in	O
green	O
,	O
whereas	O
the	O
scissile	O
peptide	O
bond	O
is	O
highlighted	O
in	O
red	O
.	O

(	O
f	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
WT	B-protein_state
β5	B-protein
and	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
mutant	B-protein_state
active	B-site
sites	I-site
illustrates	O
the	O
different	O
orientations	O
of	O
the	O
hydroxyl	O
group	O
of	O
Thr1	B-residue_name_number
and	O
the	O
thiol	O
side	O
chain	O
of	O
Cys1	B-residue_name_number
.	O

Note	O
that	O
IC50	B-evidence
values	I-evidence
depend	O
on	O
time	O
and	O
enzyme	O
concentration	O
.	O

The	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
maps	I-evidence
(	O
blue	O
mesh	O
)	O
for	O
Ser1	B-residue_name_number
(	O
brown	O
)	O
and	O
the	O
covalently	O
bound	O
ligands	O
(	O
green	O
;	O
only	O
the	O
P1	B-site
site	I-site
(	O
Leu1	B-residue_name_number
)	O
is	O
shown	O
)	O
are	O
contoured	O
at	O
1σ	O
.	O

At	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
of	O
the	O
major	O
intron	O
class	O
,	O
these	O
include	O
a	O
polypyrimidine	B-chemical
(	I-chemical
Py	I-chemical
)	I-chemical
tract	I-chemical
comprising	O
primarily	O
Us	B-residue_name
or	O
Cs	B-residue_name
,	O
which	O
is	O
preceded	O
by	O
a	O
branch	B-site
point	I-site
sequence	I-site
(	O
BPS	B-site
)	O
that	O
ultimately	O
serves	O
as	O
the	O
nucleophile	O
in	O
the	O
splicing	O
reaction	O
and	O
an	O
AG	B-chemical
-	I-chemical
dinucleotide	I-chemical
at	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
junction	O
.	O

High	O
-	O
resolution	O
structures	B-evidence
of	O
intact	B-protein_state
splicing	B-complex_assembly
factor	I-complex_assembly
–	I-complex_assembly
RNA	I-complex_assembly
complexes	O
would	O
offer	O
key	O
insights	O
regarding	O
the	O
juxtaposition	O
of	O
the	O
distinct	O
splice	B-site
site	I-site
consensus	O
sequences	O
and	O
their	O
relationship	O
to	O
disease	O
-	O
causing	O
point	O
mutations	O
.	O

In	O
turn	O
,	O
the	O
ternary	B-complex_assembly
complex	I-complex_assembly
of	O
U2AF65	B-protein
with	O
SF1	B-protein
and	O
U2AF35	B-protein
identifies	O
the	O
surrounding	O
BPS	B-site
and	O
3	B-site
′	I-site
splice	I-site
site	I-site
junctions	O
.	O

The	O
Q147	B-residue_name_number
residue	O
participates	O
in	O
hydrogen	O
bonds	O
with	O
the	O
-	O
N3H	O
of	O
the	O
eighth	B-residue_number
uracil	B-residue_name
and	O
-	O
O2	O
of	O
the	O
ninth	B-residue_number
pyrimidine	B-chemical
.	O

The	O
adjacent	O
R146	B-residue_name_number
guanidinium	O
group	O
donates	O
hydrogen	O
bonds	O
to	O
the	O
3	O
′-	O
terminal	O
ribose	B-chemical
-	O
O2	O
′	O
and	O
O3	O
′	O
atoms	O
,	O
where	O
it	O
could	O
form	O
a	O
salt	O
bridge	O
with	O
a	O
phospho	O
-	O
diester	O
group	O
in	O
the	O
context	O
of	O
a	O
longer	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
.	O

Versatile	O
primary	O
sequence	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element

The	O
adjacent	O
V249	B-residue_name_number
and	O
V250	B-residue_name_number
are	O
notable	O
for	O
their	O
respective	O
interactions	O
that	O
connect	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
at	O
this	O
distal	O
interface	B-site
from	O
the	O
RNA	B-site
-	I-site
binding	I-site
site	I-site
(	O
Fig	O
.	O
4a	O
,	O
top	O
).	O

First	O
,	O
we	O
replaced	B-experimental_method
V249	B-residue_name_number
and	O
V250	B-residue_name_number
at	O
the	O
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
and	O
V254	B-residue_name_number
at	O
the	O
bound	B-protein_state
RNA	B-chemical
site	O
with	O
glycine	B-residue_name
(	O
3Gly	B-mutant
).	O

To	O
test	O
the	O
interplay	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
with	O
its	O
N	O
-	O
and	O
C	O
-	O
terminal	O
RRM	B-structure_element
extensions	I-structure_element
,	O
we	O
constructed	B-experimental_method
an	O
internal	O
linker	B-experimental_method
deletion	I-experimental_method
of	O
20	B-residue_range
-	I-residue_range
residues	I-residue_range
within	O
the	O
extended	B-protein_state
RNA	B-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
(	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
).	O

Yet	O
,	O
it	O
is	O
well	O
known	O
that	O
the	O
linker	B-experimental_method
deletion	I-experimental_method
in	O
the	O
context	O
of	O
the	O
minimal	B-protein_state
RRM1	B-structure_element
–	O
RRM2	B-structure_element
boundaries	O
has	O
no	O
detectable	O
effect	O
on	O
the	O
RNA	B-evidence
affinities	I-evidence
of	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
compared	O
with	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
(	O
refs	O
;	O
Figs	O
1b	O
and	O
4b	O
;	O
Supplementary	O
Fig	O
.	O
4j	O
).	O

This	O
minor	O
U2AF65	B-protein
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
,	O
coupled	O
with	O
the	O
versatile	O
sequence	O
of	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
highlighted	O
the	O
potential	O
role	O
for	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
conformational	O
dynamics	O
in	O
U2AF65	B-protein
-	O
splice	O
site	O
recognition	O
.	O

Yet	O
,	O
small	B-experimental_method
-	I-experimental_method
angle	I-experimental_method
X	I-experimental_method
-	I-experimental_method
ray	I-experimental_method
scattering	I-experimental_method
(	O
SAXS	B-experimental_method
)	O
data	O
indicated	O
that	O
both	O
the	O
minimal	B-protein_state
U2AF651	B-mutant
,	I-mutant
2	I-mutant
and	O
longer	O
constructs	O
comprise	O
a	O
highly	B-protein_state
diverse	I-protein_state
continuum	I-protein_state
of	I-protein_state
conformations	I-protein_state
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
that	O
includes	O
the	O
‘	O
closed	B-protein_state
'	O
and	O
‘	O
open	B-protein_state
'	O
conformations	O
.	O

The	O
positions	O
of	O
single	O
cysteine	B-residue_name
mutations	B-experimental_method
for	O
fluorophore	B-chemical
attachment	O
(	O
A181C	B-mutant
in	O
RRM1	B-structure_element
and	O
Q324C	B-mutant
in	O
RRM2	B-structure_element
)	O
were	O
chosen	O
based	O
on	O
inspection	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
and	O
the	O
‘	O
closed	B-protein_state
'	O
model	O
of	O
apo	B-protein_state
-	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
.	O

Criteria	O
included	O
(	O
i	O
)	O
residue	O
locations	O
that	O
are	O
distant	O
from	O
and	O
hence	O
not	O
expected	O
to	O
interfere	O
with	O
the	O
RRM	B-complex_assembly
/	I-complex_assembly
RNA	I-complex_assembly
or	O
inter	B-site
-	I-site
RRM	I-site
interfaces	I-site
,	O
(	O
ii	O
)	O
inter	O
-	O
dye	O
distances	O
(	O
50	O
Å	O
for	O
U2AF651	B-complex_assembly
,	I-complex_assembly
2L	I-complex_assembly
–	I-complex_assembly
Py	I-complex_assembly
tract	I-complex_assembly
and	O
30	O
Å	O
for	O
the	O
closed	B-protein_state
apo	B-protein_state
-	O
model	O
)	O
that	O
are	O
expected	O
to	O
be	O
near	O
the	O
Förster	B-experimental_method
radius	I-experimental_method
(	I-experimental_method
Ro	I-experimental_method
)	I-experimental_method
for	O
the	O
Cy3	B-chemical
/	O
Cy5	B-chemical
pair	O
(	O
56	O
Å	O
),	O
where	O
changes	O
in	O
the	O
efficiency	O
of	O
energy	O
transfer	O
are	O
most	O
sensitive	O
to	O
distance	O
,	O
and	O
(	O
iii	O
)	O
FRET	B-evidence
efficiencies	I-evidence
that	O
are	O
calculated	O
to	O
be	O
significantly	O
greater	O
for	O
the	O
‘	O
closed	B-protein_state
'	O
apo	B-protein_state
-	O
model	O
as	O
opposed	O
to	O
the	O
‘	O
open	B-protein_state
'	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
structures	B-evidence
(	O
by	O
∼	O
30	O
%).	O

Double	O
-	O
cysteine	B-residue_name
variant	B-protein_state
of	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
was	O
modified	B-experimental_method
with	O
equimolar	O
amount	O
of	O
Cy3	B-chemical
and	O
Cy5	B-chemical
.	O

We	O
first	O
characterized	O
the	O
conformational	O
dynamics	O
spectrum	O
of	O
U2AF65	B-protein
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
(	O
Fig	O
.	O
6c	O
,	O
d	O
;	O
Supplementary	O
Fig	O
.	O
7a	O
,	O
b	O
).	O

The	O
double	O
-	O
labelled	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
protein	O
was	O
tethered	B-protein_state
to	O
a	O
slide	O
via	O
biotin	B-chemical
-	I-chemical
NTA	I-chemical
/	I-chemical
Ni	I-chemical
+	I-chemical
2	I-chemical
resin	I-chemical
.	O

We	O
conclude	O
that	O
weak	O
contacts	O
between	O
the	O
U2AF65	B-protein
RRM1	B-structure_element
and	O
RRM2	B-structure_element
permit	O
dissociation	O
of	O
these	O
RRMs	B-structure_element
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
.	O

A	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
was	O
again	O
predominant	O
,	O
indicating	O
a	O
similar	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
conformation	O
and	O
structural	O
dynamics	O
for	O
the	O
untethered	B-protein_state
and	O
tethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
).	O

Hidden	B-experimental_method
Markov	I-experimental_method
modelling	I-experimental_method
analysis	I-experimental_method
of	O
smFRET	B-experimental_method
traces	B-evidence
suggests	O
that	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
can	O
sample	O
at	O
least	O
two	O
other	O
conformations	O
corresponding	O
to	O
∼	O
0	O
.	O
7	O
–	O
0	O
.	O
8	O
and	O
∼	O
0	O
.	O
3	O
FRET	B-evidence
values	I-evidence
in	O
addition	O
to	O
the	O
predominant	O
conformation	O
corresponding	O
to	O
the	O
0	O
.	O
45	O
FRET	B-evidence
state	I-evidence
.	O

Notably	O
,	O
a	O
triple	B-protein_state
mutation	I-protein_state
of	O
three	O
residues	O
(	O
V254P	B-mutant
,	O
Q147A	B-mutant
and	O
R227A	B-mutant
)	O
in	O
the	O
respective	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
N	B-structure_element
-	I-structure_element
and	I-structure_element
C	I-structure_element
-	I-structure_element
terminal	I-structure_element
extensions	I-structure_element
non	O
-	O
additively	O
reduce	O
RNA	B-evidence
binding	I-evidence
by	O
150	O
-	O
fold	O
.	O

A	O
confirmed	O
somatic	O
mutation	O
of	O
U2AF65	B-protein
in	O
patients	O
with	O
MDS	O
,	O
L187V	B-mutant
,	O
is	O
located	O
on	O
a	O
solvent	B-site
-	I-site
exposed	I-site
surface	I-site
of	O
RRM1	B-structure_element
that	O
is	O
distinct	O
from	O
the	O
RNA	B-site
interface	I-site
(	O
Fig	O
.	O
7a	O
).	O

An	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
is	O
likely	O
to	O
correspond	O
to	O
the	O
U2AF65	B-protein
conformation	O
visualized	O
in	O
our	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
crystal	B-evidence
structures	I-evidence
,	O
in	O
which	O
the	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
bind	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
to	O
the	O
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotide	I-chemical
.	O

The	O
lesser	O
0	O
.	O
65	O
–	O
0	O
.	O
8	O
and	O
0	O
.	O
2	O
–	O
0	O
.	O
3	O
FRET	B-evidence
values	I-evidence
in	O
the	O
untethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
experiment	O
could	O
correspond	O
to	O
respective	O
variants	O
of	O
the	O
‘	O
closed	B-protein_state
',	O
back	B-protein_state
-	I-protein_state
to	I-protein_state
-	I-protein_state
back	I-protein_state
U2AF65	B-protein
conformations	O
characterized	O
by	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
data	O
,	O
or	O
to	O
extended	B-protein_state
U2AF65	B-protein
conformations	O
,	O
in	O
which	O
the	O
intramolecular	O
RRM1	B-structure_element
/	O
RRM2	B-structure_element
interactions	O
have	O
dissociated	O
the	O
protein	B-protein
is	O
bound	B-protein_state
to	I-protein_state
RNA	B-chemical
via	O
single	B-protein_state
RRMs	B-structure_element
.	O

Examples	O
of	O
‘	O
extended	B-protein_state
conformational	O
selection	O
'	O
during	O
ligand	O
binding	O
have	O
been	O
characterized	O
for	O
a	O
growing	O
number	O
of	O
macromolecules	O
(	O
for	O
example	O
,	O
adenylate	B-protein_type
kinase	I-protein_type
,	O
LAO	B-protein_type
-	I-protein_type
binding	I-protein_type
protein	I-protein_type
,	O
poly	B-protein_type
-	I-protein_type
ubiquitin	I-protein_type
,	O
maltose	B-protein_type
-	I-protein_type
binding	I-protein_type
protein	I-protein_type
and	O
the	O
preQ1	B-protein_type
riboswitch	I-protein_type
,	O
among	O
others	O
).	O

Here	O
,	O
the	O
majority	O
of	O
changes	O
in	O
smFRET	B-experimental_method
traces	B-evidence
for	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
bound	B-protein_state
to	I-protein_state
slide	O
-	O
tethered	O
RNA	B-chemical
began	O
at	O
high	O
(	O
0	O
.	O
65	O
–	O
0	O
.	O
8	O
)	O
FRET	B-evidence
value	I-evidence
and	O
transition	O
to	O
the	O
predominant	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
(	O
Supplementary	O
Fig	O
.	O
7c	O
–	O
g	O
).	O

(	O
a	O
)	O
Alignment	B-experimental_method
of	O
oligonucleotide	B-chemical
sequences	O
that	O
were	O
co	B-experimental_method
-	I-experimental_method
crystallized	I-experimental_method
in	O
the	O
indicated	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
.	O

The	O
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
and	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structure	B-evidence
are	O
compared	O
in	O
Supplementary	O
Fig	O
.	O
3a	O
–	O
h	O
.	O
The	O
first	B-site
and	I-site
seventh	I-site
U2AF651	I-site
,	I-site
2L	I-site
-	I-site
binding	I-site
sites	I-site
are	O
unchanged	O
from	O
the	O
prior	O
dU2AF651	B-complex_assembly
,	I-complex_assembly
2	I-complex_assembly
–	I-complex_assembly
RNA	I-complex_assembly
structure	B-evidence
and	O
are	O
portrayed	O
in	O
Supplementary	O
Fig	O
.	O
3a	O
,	O
f	O
.	O
The	O
four	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
are	O
similar	O
with	O
the	O
exception	O
of	O
pH	O
-	O
dependent	O
variations	O
at	O
the	O
ninth	B-site
site	I-site
that	O
are	O
detailed	O
in	O
Supplementary	O
Fig	O
.	O
3i	O
,	O
j	O
.	O
The	O
representative	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structure	B-evidence
shown	O
has	O
the	O
highest	O
resolution	O
and	O
/	O
or	O
ribose	B-chemical
nucleotide	I-chemical
at	O
the	O
given	O
site	O
:	O
(	O
a	O
)	O
rU2	B-residue_name_number
of	O
structure	O
iv	O
;	O
(	O
b	O
)	O
rU3	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
c	O
)	O
rU4	B-residue_name_number
of	O
structure	O
i	O
;	O
(	O
d	O
)	O
rU5	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
e	O
)	O
rU6	B-residue_name_number
of	O
structure	O
ii	O
;	O
(	O
f	O
)	O
dU8	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
g	O
)	O
dU9	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
h	O
)	O
rC9	B-residue_name_number
of	O
structure	O
iv	O
.	O

(	O
i	O
)	O
Bar	O
graph	O
of	O
apparent	O
equilibrium	B-evidence
affinities	I-evidence
(	O
KA	B-evidence
)	O
of	O
the	O
wild	B-protein_state
type	I-protein_state
(	O
blue	O
)	O
and	O
the	O
indicated	O
mutant	B-protein_state
(	O
yellow	O
)	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
proteins	O
binding	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
5	B-chemical
′-	I-chemical
CCCUUUUUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′).	I-chemical

The	O
U2AF65	B-protein
linker	B-structure_element
/	O
RRM	B-structure_element
and	O
inter	O
-	O
RRM	B-structure_element
interactions	O
.	O

U2AF65	B-protein
inter	O
-	O
domain	O
residues	O
are	O
important	O
for	O
splicing	O
a	O
representative	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
substrate	O
in	O
human	B-species
cells	O
.	O

(	O
a	O
)	O
Schematic	O
diagram	O
of	O
the	O
pyPY	B-chemical
reporter	O
minigene	O
construct	O
comprising	O
two	O
alternative	O
splice	B-site
sites	I-site
preceded	O
by	O
either	O
the	O
weak	O
IgM	O
Py	B-chemical
tract	I-chemical
(	O
py	B-chemical
)	O
or	O
the	O
strong	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
PY	B-chemical
)	O
(	O
sequences	O
inset	O
).	O

RNA	O
binding	O
stabilizes	O
the	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
conformation	O
of	O
U2AF65	B-protein
RRMs	B-structure_element
.	O

The	O
untethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
protein	O
(	O
1	O
nM	O
)	O
was	O
added	O
to	O
AdML	B-gene
RNA	B-chemical
–	I-chemical
polyethylene	I-chemical
-	I-chemical
glycol	I-chemical
-	I-chemical
linker	I-chemical
–	I-chemical
DNA	I-chemical
oligonucleotide	I-chemical
(	O
10	O
nM	O
),	O
which	O
was	O
immobilized	O
on	O
the	O
microscope	O
slide	O
by	O
annealing	O
with	O
a	O
complementary	O
biotinyl	B-chemical
-	I-chemical
DNA	I-chemical
oligonucleotide	I-chemical
(	O
black	O
vertical	O
line	O
).	O

A	O
surface	O
representation	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
is	O
shown	O
bound	B-protein_state
to	I-protein_state
nine	O
nucleotides	B-chemical
(	O
nt	O
);	O
the	O
relative	O
distances	O
and	O
juxtaposition	O
of	O
the	O
branch	B-site
point	I-site
sequence	I-site
(	O
BPS	B-site
)	O
and	O
consensus	O
AG	B-chemical
dinucleotide	I-chemical
at	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
are	O
unknown	O
.	O

